Schedule 13G ownership disclosure

DIFFUSION PHARMACEUTICALS IN

Security class unavailable · CUSIP: 253748206

Event date: 2016-08-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.0500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-17-028525
Form type
SC 13G/A
Filer
CervoMed Inc.
CIK
CIK 1053691
Filed
Feb 02, 2017
Reporting period
Aug 17, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub